Delora stop Uses

How do you administer this medicine?
sponsored

What is Delora stop?

Delora stop is an antihistamine that reduces the effects of the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.

Delora stop is used to treat the symptoms of allergies, such as sneezing, watery eyes, and runny nose. It is also used to treat skin hives and itching in people with chronic skin reactions.

Delora stop may also be used for purposes not listed in this medication guide.

Delora stop indications

An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
sponsored

1.1 Seasonal Allergic Rhinitis

Delora stop Tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older.

1.2 Perennial Allergic Rhinitis

Delora stop Tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older.

1.3 Chronic Idiopathic Urticaria

Delora stop Tablets are indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 12 years of age and older.

How should I use Delora stop?

Use Delora stop orally disintegrating tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Ask your health care provider any questions you may have about how to use Delora stop orally disintegrating tablets.

Uses of Delora stop in details

There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.
sponsored

Use: Labeled Indications

Allergic rhinitis: Relief of nasal and non-nasal symptoms of seasonal (SAR) and perennial (PAR) allergic rhinitis

Urticaria: Symptomatic relief of pruritus, reduction in number of hives, and reduction in size of hives associated with chronic idiopathic urticaria (CIU)

Off Label Uses

NSAID-associated urticaria (prophylaxis)

Data from a retrospective study with a limited number of patients suggest that Delora stop may be beneficial for prophylactic therapy in patients with NSAID-associated urticaria prior to receiving a strong COX-1 inhibitor. Additional trials may be needed to further define the role of Delora stop in this setting.

Delora stop description

Delora stop Tab: Each tablet contains 5.0 mg of Delora stop.

Delora stop Syr: Each mL of Delora stop syrup contains 500 mcg of Delora stop.

Excipients/Inactive Ingredients: Delora stop Tab: Dibasic calcium phosphate dihydrate, microcrystalline cellulose, maize starch, talc, blue color film-coat material, clear film coat material, white wax and carnauba wax.

Delora stop dosage

sponsored

Delora stop Dosage

Generic name: Delora stop 5mg

Dosage form: tablet, film coated; oral solution

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

Although an orally disintegrating tablet formulation of Delora stop may be available in the marketplace, Delora stop® RediTabs® Tablets are no longer marketed.

Delora stop Tablets,

Oral Solution, or RediTabs Tablets may be taken without regard to meals. Place Delora stop (Delora stop) RediTabs Tablets on the tongue and allow to disintegrate before swallowing. Tablet disintegration occurs rapidly. Administer with or without water. Take tablet immediately after opening the blister.

The age-appropriate dose of Delora stop

Oral Solution should be administered with a commercially available measuring dropper or syringe that is calibrated to deliver 2 mL and 2.5 mL (½ teaspoon).

Adults and Adolescents 12 Years of Age and Over

The recommended dose of Delora stop Tablets or Delora stop Tablets is one 5-mg tablet once daily. The recommended dose of Delora stop

Oral Solution is 2 teaspoonfuls (5 mg in 10 mL) once daily.

Children 6 to 11 Years of Age

The recommended dose of Delora stop

Oral Solution is 1 teaspoonful (2.5 mg in 5 mL) once daily. The recommended dose of Delora stop Tablets is one 2.5-mg tablet once daily.

Children 12 Months to 5 Years of Age

The recommended dose of Delora stop

Oral Solution is ½ teaspoonful (1.25 mg in 2.5 mL) once daily.

Children 6 to 11 Months of Age

The recommended dose of Delora stop

Oral Solution is 2 mL (1 mg) once daily.

Adults with Hepatic or Renal Impairment

In adult patients with liver or renal impairment, a starting dose of one 5-mg tablet every other day is recommended based on pharmacokinetic data. Dosing recommendation for children with liver or renal impairment cannot be made due to lack of data.

More about Delora stop (Delora stop)

Consumer resources

Professional resources

Other formulations

Related treatment guides

Delora stop interactions

See also:
What other drugs will affect Delora stop?

sponsored

Inhibitors Of Cytochrome P450 3A4

In controlled clinical studies co-administration of Delora stop with ketoconazole, erythromycin, or azithromycin resulted in increased plasma concentrations of Delora stop and 3 hydroxydesloratadine, but there were no clinically relevant changes in the safety profile of Delora stop.

Fluoxetine

In controlled clinical studies co-administration of Delora stop with fluoxetine, a selective serotonin reuptake inhibitor (SSRI), resulted in increased plasma concentrations of Delora stop and 3 hydroxydesloratadine, but there were no clinically relevant changes in the safety profile of Delora stop.

Cimetidine

In controlled clinical studies co-administration of Delora stop with cimetidine, a histamine H2-receptor antagonist, resulted in increased plasma concentrations of Delora stop and 3 hydroxydesloratadine, but there were no clinically relevant changes in the safety profile of Delora stop.

Drug Abuse And Dependence

There is no information to indicate that abuse or dependency occurs with Delora stop Tablets.

Delora stop side effects

See also:
What are the possible side effects of Delora stop?

The following adverse reactions are discussed in greater detail in other sections of the label:

Clinical Trials Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.

Adults and Adolescents

Allergic Rhinitis: In multiple-dose placebo-controlled trials, 2834 patients ages 12 years or older received Delora stop tablets at doses of 2.5 mg to 20 mg daily, of whom 1655 patients received the recommended daily dose of 5 mg. In patients receiving 5 mg daily, the rate of adverse events was similar between Delora stop and placebo-treated patients. The percent of patients who withdrew prematurely due to adverse events was 2.4% in the Delora stop group and 2.6% in the placebo group. There were no serious adverse events in these trials in patients receiving Delora stop. All adverse events that were reported by greater than or equal to 2% of patients who received the recommended daily dose of Delora stop tablets (5 mg once daily), and that were more common with Delora stop tablets than placebo, are listed in Table 1.

The frequency and magnitude of laboratory and electrocardiographic abnormalities were similar in Delora stop and placebo-treated patients.

There were no differences in adverse events for subgroups of patients as defined by gender, age, or race.

Chronic Idiopathic Urticaria: In multiple-dose, placebo-controlled trials of chronic idiopathic urticaria, 211 patients ages 12 years or older received Delora stop tablets and 205 received placebo. Adverse events that were reported by greater than or equal to 2% of patients who received Delora stop tablets and that were more common with Delora stop than placebo were (rates for Delora stop and placebo, respectively): headache (14%, 13%), nausea (5%, 2%), fatigue (5%, 1%), dizziness (4%, 3%), pharyngitis (3%, 2%), dyspepsia (3%, 1%), and myalgia (3%, 1%).

Pediatrics

Two hundred and forty-six pediatric subjects 6 months to 11 years of age received Delora stop

Oral Solution for 15 days in three placebo-controlled clinical trials. Pediatric subjects aged 6 to 11 years received 2.5 mg once a day, subjects aged 1 to 5 years received 1.25 mg once a day, and subjects 6 to 11 months of age received 1.0 mg once a day.

In subjects 6 to 11 years of age, no individual adverse event was reported by 2 percent or more of the subjects.

In subjects 2 to 5 years of age, adverse events reported for Delora stop and placebo in at least 2 percent of subjects receiving Delora stop

Oral Solution and at a frequency greater than placebo were fever (5.5%, 5.4%), urinary tract infection (3.6%, 0%) and varicella (3.6%, 0%).

In subjects 12 months to 23 months of age, adverse events reported for the Delora stop product and placebo in at least 2 percent of subjects receiving Delora stop

Oral Solution and at a frequency greater than placebo were fever (16.9%, 12.9%), diarrhea (15.4%, 11.3%), upper respiratory tract infections (10.8%, 9.7%), coughing (10.8%, 6.5%), appetite increased (3.1%, 1.6%), emotional lability (3.1%, 0%), epistaxis (3.1%, 0%), parasitic infection (3.1%, 0%), pharyngitis (3.1%, 0%), rash maculopapular (3.1%, 0%).

In subjects 6 months to 11 months of age, adverse events reported for Delora stop and placebo in at least 2 percent of subjects receiving Delora stop

Oral Solution and at a frequency greater than placebo were upper respiratory tract infections (21.2%, 12.9%), diarrhea (19.7%, 8.1%), fever (12.1%, 1.6%), irritability (12.1%, 11.3%), coughing (10.6%, 9.7%), somnolence (9.1%, 8.1%), bronchitis (6.1%, 0%), otitis media (6.1%, 1.6%), vomiting (6.1%, 3.2%), anorexia (4.5%, 1.6%), pharyngitis (4.5%, 1.6%), insomnia (4.5%, 0%), rhinorrhea (4.5%, 3.2%), erythema (3.0%, 1.6%), and nausea (3.0%, 0%).

There were no clinically meaningful changes in any electrocardiographic parameter, including the QTc interval. Only one of the 246 pediatric subjects receiving Delora stop

Oral Solution in the clinical trials discontinued treatment because of an adverse event.

Post-Marketing Experience

Because adverse events are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. The following spontaneous adverse events have been reported during the marketing of Delora stop: tachycardia, palpitations, rare cases of hypersensitivity reactions (such as rash, pruritus, urticaria, edema, dyspnea, and anaphylaxis), psychomotor hyperactivity, movement disorders (including dystonia, tics, and extrapyramidal symptoms), seizures, and elevated liver enzymes including bilirubin, and very rarely, hepatitis.

Delora stop contraindications

See also:
What is the most important information I should know about Delora stop?

You should not take this medication if you are allergic to Delora stop or to loratadine (Claritin).

Before taking Delora stop, tell your doctor if you are allergic to any drugs, or if you have liver or kidney disease.

Do not give this medication to a child younger than 2 years old without the advice of a doctor.

Delora stop disintegrating tablets (Delora stop) may contain phenylalanine. Talk to your doctor before using this form of Delora stop if you have phenylketonuria (PKU).

Active ingredient matches for Delora stop:

Desloratadine in Egypt.


List of Delora stop substitutes (brand and generic names)

Sort by popularity
Unit description / dosage (Manufacturer)Price, USD
DELORID TABLET 1 strip / 10 tablets each (Zyris Derma Care (P) Ltd)$ 0.53
DELORTA Capsule/ Tablet / 5mg / 10 units (Abbott Healthcare Pvt Ltd (AHPL))$ 0.68
5 mg x 10's (Abbott Healthcare Pvt Ltd (AHPL))$ 0.63
Delorta 5mg TAB / 10 (Abbott Healthcare Pvt Ltd (AHPL))$ 0.63
Delorta 5 mg Tablet (Abbott Healthcare Pvt Ltd (AHPL))$ 0.06
DELORTA tab 5 mg x 10's (Abbott Healthcare Pvt Ltd (AHPL))$ 0.63
Delorta 5mg TAB / 10 (Abbott Healthcare Pvt Ltd (AHPL))$ 0.63
Delotid 5mg TAB / 10 (DWD)
5 mg x 10's (DWD)
DELOTID tab 5 mg x 10's (DWD)$ 0.66
Denosin 5 mg x 50 x 10's
Denosin 20 mg x 10 Blister x 10 Tablet
DES - OD Capsule/ Tablet / 5mg / 10 units (Cadila Pharmaceuticals (Le Sante Division))$ 0.65
Des OD 5 mg x 10 Blister x 10 Tablet (Le Sante (Cadila Pharmaceuticals Ltd.))
Des OD 5 mg Tablet (Le Sante (Cadila Pharmaceuticals Ltd.))$ 0.07
DES OD 10 MG TABLET 1 strip / 10 tablets each (Le Sante (Cadila Pharmaceuticals Ltd.))$ 0.79
Des OD 10mg Tablet (Le Sante (Cadila Pharmaceuticals Ltd.))$ 0.09
Des-OD 5mg FC-TAB / 10 (Cadila (Le Sante))$ 0.57
5 mg x 10's (Cadila (Le Sante))$ 0.57
DES-OD film-coated tab 5 mg x 10's (Cadila (Le Sante))$ 0.57

References

  1. DailyMed. "DESLORATADINE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
  2. PubChem. "Desloratadine". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
  3. DrugBank. "Desloratadine". http://www.drugbank.ca/drugs/DB00967 (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Delora stop are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Delora stop. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet


Consumer reported price estimates

No survey data has been collected yet


1 consumer reported time for results

To what extent do I have to use Delora stop before I begin to see changes in my health conditions?
As part of the reports released by ndrugs.com website users, it takes 1 week and a few days before you notice an improvement in your health conditions.
Please note, it doesn't mean you will start to notice such health improvement in the same time frame as other users. There are many factors to consider, and we implore you to visit your doctor to know how long before you can see improvements in your health while taking Delora stop. To get the time effectiveness of using Delora stop drug by other patients, please click here.
Users%
1 week1
100.0%


Consumer reported age

No survey data has been collected yet


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 19 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2022 ndrugs.com All Rights Reserved